Regulatory Science Research in Tobacco Product Assessment

The contract focuses on conducting comprehensive public health research related to tobacco product use, encompassing behavioral studies, clinical observations, and analysis of policy impacts. The research aims to generate evidence that will inform and support regulatory decisions made by the FDA, ensuring that the agency’s regulatory actions are grounded in robust scientific data. It addresses multiple facets of tobacco use and its implications, which is critical for evaluating products under FDA oversight. This subcontract, issued by the FDA Office of Acquisitions and Grants Services within the Department of Health and Human Services, is identified under NAICS code 541990 and will be performed in Silver Spring. The contract prioritizes research activities that contribute to tobacco product assessment through a regulatory science lens, facilitating the FDA’s mission to protect public health. The focus on evidence-driven analysis highlights the importance of integrating behavioral, clinical, and policy-related research elements to comprehensively understand tobacco product impacts.